In NSCLC patients, our findings revealed that those with higher BCAM expression levels, as indicated by the average AQUA score, had improved overall survival when the population was divided into two groups using the median cut point and the visual threshold. This evidence concerns the gene BCAM and non-small cell lung carcinoma.